Answers are grounded in this paper and cite their sources.
Codonopsis polysaccharides exhibit diverse biological activities, but their antiviral effects against the H1N1 influenza A virus and how these activities change after sulfation modification remains unclear. In this study, crude Codonopsis polysaccharide (COP) was obtained via water extraction and alcohol precipitation, and COP-1 (2.1 × 103 Da, β-D-(2 → 1)-fructan) was isolated and purified. Both COP and COP-1 were modified by sulfation using the sulfur trioxide-pyridine method, yielding derivatives SCOP and SCOP-1 with degrees of substitution of 1.792 and 1.403, respectively. Antiviral activity was evaluated in MDCK cells using MTT and TCID₅₀ assays, revealing that COP, SCOP, and SCOP-1 all inhibited H1N1 replication, with sulfation significantly enhancing antiviral activity. Time-of-addition experiments indicated that inhibition occurred during the early phase of infection (0-4 h). Annexin V-PI staining confirmed that these compounds reduced virus-induced early apoptosis. In H1N1-infected A549 cells, they suppressed NF-κB p65 phosphorylation and downregulated the expression of IL-6, IL-8, MCP-1, CCL-5, TNF-α, and TRAIL. Overall, Codonopsis polysaccharides and their sulfated derivatives exert anti-influenza effects through a triple mechanism involving inhibition of early viral replication, anti-apoptotic activity, and anti-inflammatory action, making them promising candidates for antiflu therapeutics.
No takes yet. Share an insight, caveat, or question.
Song et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: